Literature DB >> 27080459

MRI assessment of regional differences in phosphorus-31 metabolism and morphological abnormalities of the foot muscles in diabetes.

Yu-Ching Lin1,2, Jim Wu1, Dimitrios Baltzis3, Aristidis Veves3, Robert L Greenman1,4.   

Abstract

PURPOSE: To assess differences in the phosphorus-31 (31 P) metabolism and morphology in multiple muscle regions in the forefoot of diabetic patients and normal subjects.
MATERIALS AND METHODS: Fifteen diabetic patients and 15 normal subjects were assessed for muscle atrophy by 1 H magnetic resonance imaging (MRI) at 3T to grade the flexor hallucis, adductor hallucis, interosseous regions, and entire foot cross-section. Each region and the entire foot were also quantitatively evaluated for metabolic function using 31 P imaging for spatial mapping of the inorganic phosphate (Pi) to phosphocreatine (PCr) ratio (Pi/PCr). The ratio of viable muscle area to the predefined region areas (31 P/1 H) was calculated. The variability of each method was assessed by its coefficient of variation (CV).
RESULTS: Muscle atrophy was significantly more severe in diabetic compared to normal subjects in all regions (P < 0.01). The 31 P/1 H area ratio was significantly larger in the adductor hallucis than in the other two regions (P < 0.05). The Pi/PCr ratio was significantly different between the two groups in the flexor hallucis and interosseous regions (P < 0.05) but not adductor hallucis region. The CV for Pi/PCr ranged from 10.13 to 55.84, while it ranged from 73.40 to 263.90 for qualitative grading.
CONCLUSION: Changes in atrophy and metabolism appear to occur unequally between different regions of the forefoot in diabetes. The adductor hallucis region appears more capable of maintaining structural and metabolic integrity than the flexor hallucis or interosseous regions. The CV analysis suggests that the quantitative 31 P methods have less variability than the qualitative grading. J. Magn. Reson. Imaging 2016;44:1132-1142.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  diabetic foot; magnetic resonance spectroscopy; multinuclear imaging; muscle metabolism; musculosketetal MRI; phosphorus-31 imaging

Mesh:

Substances:

Year:  2016        PMID: 27080459     DOI: 10.1002/jmri.25278

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  Hip joint torques in type II diabetes with and without neuropathy.

Authors:  Laleh Abadi; Zahra Salahzadeh; Mandana Rezaei; Ali E Oskouei; Mahmood Reza Azghani
Journal:  Hong Kong Physiother J       Date:  2017-03-16

2.  New insights into intrinsic foot muscle morphology and composition using ultra-high-field (7-Tesla) magnetic resonance imaging.

Authors:  Melinda M Franettovich Smith; James M Elliott; Aiman Al-Najjar; Kenneth A Weber; Mark A Hoggarth; Bill Vicenzino; Paul W Hodges; Natalie J Collins
Journal:  BMC Musculoskelet Disord       Date:  2021-01-21       Impact factor: 2.362

3.  Fat Is Consistently Present within the Plantar Muscular Space of the Human Foot-An Anatomical Study.

Authors:  Joanna Tomlinson; Stefan Klima; Amélie Poilliot; Johann Zwirner; Niels Hammer
Journal:  Medicina (Kaunas)       Date:  2022-01-20       Impact factor: 2.430

4.  Phosphorous Magnetic Resonance Spectroscopy to Detect Regional Differences of Energy and Membrane Metabolism in Naïve Glioblastoma Multiforme.

Authors:  Lisa Maria Walchhofer; Ruth Steiger; Andreas Rietzler; Johannes Kerschbaumer; Christian Franz Freyschlag; Günther Stockhammer; Elke Ruth Gizewski; Astrid Ellen Grams
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

5.  Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation.

Authors:  Astrid Ellen Grams; Stephanie Mangesius; Ruth Steiger; Ivan Radovic; Andreas Rietzler; Lisa Maria Walchhofer; Malik Galijašević; Julian Mangesius; Martha Nowosielski; Christian Franz Freyschlag; Johannes Kerschbaumer; Elke Ruth Gizewski
Journal:  Curr Oncol       Date:  2021-12-01       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.